Risk of long COVID is higher in women and a link between SARS-CoV-2 infection and development of ME/CFS is shown, according ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ...

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a ...

The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

Investigators from Mass General Brigham​ have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273), which produce the SARS-CoV-2 spike protein to activate potent B and ...

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

During the COVID-19 pandemic, health worker Maria Tereza Malheiros Sapienza's curiosity was aroused by her immunity to ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.